VivoSeq
Other

Ovarian Cyst

10

Pipeline Programs

2

Active Trials

6

Companies Involved

Ovarian cyst is an early-stage landscape with 10 programs across 6 companies. The most active players are Solvay Pharmaceuticals, AbbVie, McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.. 4 therapies are approved with 3 more in late-stage development.

Pipeline Metrics

Competitive Density

37/100

Pipeline Velocity

6/100

Mech. Concentration

20/100

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

Trial Status

9

clinical trials

Unknown status5 · 56%
Recruiting2 · 22%
Completed2 · 22%

Trial Activity

9 trials

The Efficacy of Progestins in Treatment of Functional Ovarian Cyst
Unknown status··Phase 1·NCT03456570·90 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)